Areti Health

We are attending OCT New England! Connect with Paul and Niambi at the conference, we are excited to see you! Book your time here: https://lnkd.in/gzqbVaPj

We're #hiring a Python Developer in Latin America and Canada. Please apply today or share this post with your network.

Paul Neyman and I had a chance to sit down with Liam Eves, a clinical research executive and thought leader, to talk about the groundbreaking opportunity presented by generative AI for the clinical trial industry in general and specifically for patient recruitment. Patient recruitment currently constitutes 30% of the study length, 55% of study terminations are due to slow recruitment, 80% of clinical trials are delayed due to insufficient enrollment, the majority of research sites fail to recruit a critical mass of patients, and each day of delay costs sponsors $600K in lost revenue. In addition, the number of clinical trial starts per year has steadily grown from 2,000 in the year 2000 to 40,000 in 2023 while the US adult population pool has stayed the same at 4%. And here is another trend. As clinical research focus shifts to precision medicine, it becomes harder to find participants who fit increasingly selective criteria. For example, finding eligible trial participants is far more challenging for oncology trials, where 4x more candidates have to be screened per study-completing patient compared to non-oncology trials. We are a venture-funded Silicon Valley generative AI company that significantly accelerates clinical trial recruitment. Our AI Coordinator provides empathetic and to-the-point responses to leads' questions and concerns, carries out pre-qualification, and schedules on-site screening visits in minutes without human involvement. Our modern user experience that is available 24/7 provides a great start for patients in their clinical research journey. On the backend we integrate into research sites' clinical trial management systems (CTMSs) to automate a

BEKhealth, a leader in AI-powered patient identification and matching technology, is excited to announce a strategic partnership with Areti Health, known for its development of a generative AI Coordinator to dramatically improve patient recruitment and streamline site operations. This partnership establishes an industry leading end-to-end solution that integrates cutting-edge AI technologies to accelerate study timelines and improve patient diversity and access while enhancing site efficiency and patient experience. Through this partnership, BEKhealth will harness the precision of its BEKplatform for Electronic Medical Records (EMR) known to identify ten times more protocol-eligible candidates to appropriate clinical trials. Areti Health’s generative AI Coordinator will complement this by engaging pre-identified patients, prescreening, scheduling visits, and supporting sites through enrollment. This approach boosts the conversion rate to a remarkable 63%. Read the full press release here: https://lnkd.in/ghnTUijC

Areti Health is excited to be an Alliance Sponsor for upcoming Society for Clinical Research Sites (SCRS) 2024 conference! Paul Neyman and Niambi Blodgett will be representing Areti Health at the conference, and we can't wait to meet all our current customers and prospects. Book the time with our team now! https://lnkd.in/gzqbVaPj #SCRS2024 #clinicaltrials #AretiHealth

Areti Health is thrilled to announce closing our first institutional funding round led by Preface Ventures and Almaz Capital. This funding will fuel our mission of harnessing the power of generative AI to revolutionize clinical trial recruitment space. Our technology engages and educates patients about the clinical trial, pre-qualifies and schedules them for appointment in minutes — all autonomously without human coordinator involvement. It analyzes patient behavior and signals and alerts coordinating and recruiting teams for prompt follow-up whenever relevant. With the help of generative AI our coordinator speaks over 50 languages and improves access for underserved populations, patients with disabilities, and non-native English speakers. We provide an end-to-end recruitment solution starting with running lead sourcing digital media campaigns, connecting to EMR, and lead databases. Our recruitment technology significantly accelerates study timelines, improves patient diversity and access, frees up research site staff, automates recruitment workflows, and cuts advertising spending. We integrate with all major CTMS systems and we are an official CRIO partner. Our deep integration allows us to perform real-time scheduling and patient record creation with traits, pre-qualification results and conversational logs. Clinical research teams that use our AI Coordinator experience up to 10x boost in recruitment acceleration, improved site and staff efficiency, lowered advertising spending, higher patient satisfaction and better diversity metrics. Our mission is to revolutionize clinical trial recruitment by building generative AI-based solutions that outperform humans in routine cases which eat up the majority of human bandwidth today and significantly slow down clinical trials. The AI opportunity is well recognized by the clinical trial industry and we are fortunate to be first to market with the recruitment engine. We now aim at cementing our position as a recruitment market leader by building customizable end-to-end solutions that we strongly believe are the only way to add core customer value. Sincere gratitude to our amazing investors Farooq Abbasi, Pasha Bogdanov, Felix Shpilman, Seva Fridman, Anna Dvornikova, Ilya Strebulaev, Igor Tikhturov, Oleg Tikhturov, Linda Lee, Diego Sternberg, Andrés Lawson and Agustin Di Luciano for their belief in us and our vision! If you are a research site, a CRO, or a sponsor interested in boosting your recruitment by up to 10x, accelerating and derisking your studies, freeing up coordinator staff, reducing your ad spend, and strengthening operations, please get in touch with us on LinkedIn or drop us a line at contact@aretihealth.com. 

Areti Health is thrilled to announce that Niambi Blodgett has joined us as a Director of Customer Advocacy! Niambi joins us as a veteran in patient recruitment for clinical studies having built recruitment and community engagement capabilities from the ground up at EmVenio Research. As we are scaling up our operations, Niambi will be spearheading our customer-focused approach and engagement with with site networks, CROs and sponsors. Welcome aboard, Niambi!

We are thrilled to announce a new partnership with CRIO! In the world of CTMS systems, CRIO is a clear innovation leader, always pushing the edge, and we are privileged to have a fantastic partner that cements the foundation on which we build the next generation of patient recruitment for clinical trials. #ctms #clinicaltrials #geneativeai #ai

We are very lucky to have an amazing technology partner in CRIO, a top clinical trial management system, to help bring our 10x patient recruitment boost to many more studies using generative AI. Huge thanks to Raymond Nomizu, Nikita Gandhi, Andrew Davidson, and the entire CRIO team.

Thank you, Kurt Mussina and Paradigm Clinical Research for a joint executive interview with Ilya Gluhovsky and Paul Neyman conducted by Moe Alsumidaie and Clinical Trial Vanguard. Great insights and perspectives on generative AI application in clinical trial recruitment and the cutting edge innovation Areti Health is bringing to accelerate recruitment, shorten the timelines of clinical trials and ultimately bring the much needed treatment and therapy to the patients sooner. #ai #generativeai #clinicaltrials